X
1. 714269-57-5
2. Methyl 1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-alpha-d-glucopyranoside
3. (2s,3r,4s,5s,6r)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
4. (2s,3r,4s,5s,6r)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)-2-methoxy-tetrahydropyran-3,4,5-triol
5. Methyl 1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-alpha-d-glucopyranoside
6. Methyl 1-c-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-alpha-d-glucopyranoside
7. Methoxy Dapagliflozin
8. Unii-bwh63g5pjq
9. Bwh63g5pjq
10. Schembl3799163
11. Dtxsid50647404
12. Amy16482
13. Mfcd27923102
14. Zinc38428909
15. Akos022175168
16. Ac-27655
17. As-47025
18. Db-109072
19. N-propargyl-1(r)-aminoindan Methanesulfonate
20. J3.497.284b
21. F11508
22. 1?-methoxy Dapagliflozin, 1?-o-methyl Dapagliflozin
23. (1r)-2,3-dihydro-n-2-propynl-1h-inden-1-amine Methanesulfonate
24. Methyl 1-(3-(4-ethoxybenzyl)-4-chlorophenyl)-alpha-d-glucopyranoside
25. Alpha-d-glucopyranoside, Methyl 1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-
26. (2s,3r,4s,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl) Phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2h-pyran-3,4,5-triol
27. Methyl 1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-?-d-glucopyranoside; (2s,3r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2h-pyran-3,4,5-triol
| Molecular Weight | 438.9 g/mol |
|---|---|
| Molecular Formula | C22H27ClO7 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 438.1445309 g/mol |
| Monoisotopic Mass | 438.1445309 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 530 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
List of SuppliersNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Market Place
SuanFarma is present in all origins: Natural, Chemical & Biotechnological.
